{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:30:15Z","timestamp":1784071815883,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.autrev.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T19:31:49Z","timestamp":1364326309000},"page":"967-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies \u2014 Novel tool for diagnostics and patient follow-up"],"prefix":"10.1016","volume":"12","author":[{"given":"Liv T.","family":"Osnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Nakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Bodolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.02.003_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0962-8924(00)01856-0","article-title":"The molecular basis of T helper 1 and T helper2 cell differentiation","volume":"10","author":"O'Garra","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T-cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.02.003_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1189\/jlb.0206095","article-title":"Development and function of naturally occurring CD4+CD25+ regulatory cells","volume":"80","author":"Toda","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autrev.2011.06.010","article-title":"B-cells and their targeting in rheumatoid arthritis \u2014 current concepts and future perspectives","volume":"11","author":"Nakken","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/03009740600709790","article-title":"Regulatory T-cells in peripheral blood of patients with mixed connective tissue disease","volume":"35","author":"Bar\u00e1th","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T-cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2013.02.003_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/berh.1999.0081","article-title":"Unclassified or undifferentiated connective tissue disease","volume":"14","author":"Alarcon","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/art.1780230312","article-title":"Undifferentiated connective tissue syndromes","volume":"23","author":"LeRoy","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.003_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","article-title":"Undifferentiated connective tissue disease","volume":"6","author":"Mosca","year":"2000","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0050","first-page":"261","article-title":"Early undifferentiated connective tissue disease. V. An inception cohort 5years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases","volume":"25","author":"Williams","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0055","first-page":"816","article-title":"Early undifferentiated connective tissue disease (CTD) VI: an inception cohort after 10years: disease remissions and changes in diagnoses in well established and undifferentiated CTD","volume":"26","author":"Williams","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0060","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/intimm\/dxn056","article-title":"Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease","volume":"20","author":"Szodoray","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/03009741003781951","article-title":"Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease","volume":"39","author":"Zold","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2010.09.018","article-title":"Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease","volume":"10","author":"Zold","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0075","series-title":"Sj\u00f6gren's syndrome and associated disorders","first-page":"1","article-title":"Sj\u00f6gren's syndrome","author":"Zeher","year":"2006"},{"key":"10.1016\/j.autrev.2013.02.003_bb0080","series-title":"Sj\u00f6gren's syndrome and associated disorders","first-page":"27","article-title":"Selected molecular aspects behind the clinical picture of Sj\u00f6gren's syndrome","author":"Szodoray","year":"2006"},{"key":"10.1016\/j.autrev.2013.02.003_bb0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.0300-9475.2004.01432.x","article-title":"Circulating cytokines in primary Sj\u00f6gren's syndrome determined by a multiplex cytokine array system","volume":"59","author":"Szodoray","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0090","first-page":"411","article-title":"Circulating levels of Th1\/Th2 cytokines in patients with primary Sj\u00f6gren's syndrome: correlation with clinical and immunological features","volume":"19","author":"Garc\u00edc-Carrasco","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.003_bb0095","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in Sj\u00f6gren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1601-0825.2002.02846.x","article-title":"Current issues in Sj\u00f6gren's syndrome","volume":"8","author":"Jonsson","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2013.02.003_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/03009740801910361","article-title":"Immunological alterations in newly diagnosed primary Sj\u00f6gren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines","volume":"37","author":"Szodoray","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2249.2009.03966.x","article-title":"Cells with regulatory function of the innate and adaptive immune system in primary Sj\u00f6gren's syndrome","volume":"157","author":"Szodoray","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sj\u00f6gren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/rheumatology\/kep374","article-title":"The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2013.02.003_bb0125","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","article-title":"Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity","volume":"125","author":"Horikawa","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0140","first-page":"283","article-title":"Reduced circulating natural killer T cells and gamma\/delta T cells in patients with systemic sclerosis","volume":"32","author":"Riccieri","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930802282651","article-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","volume":"42","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.02.003_bb0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2013.02.003_bb0160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncprheum0618","article-title":"Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma","volume":"3","author":"Deleuran","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.003_bb0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clim.2011.09.014","article-title":"Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis","volume":"142","author":"Papp","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0180","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-012-2000-x","article-title":"The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis","volume":"31","author":"Papp","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease \u2014 an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2013.02.003_bb0190","series-title":"Mixed connective tissue disease and antinuclear antibodies","first-page":"23","article-title":"Diagnostic criteria for classification of MCTD","author":"Sharp","year":"1987"},{"key":"10.1016\/j.autrev.2013.02.003_bb0330","series-title":"Mixed connective tissue disease and antinuclear antibodies","first-page":"41","article-title":"Preliminary diagnostic criteria for classification of mixed connective tissue disease","author":"Kasukawa","year":"1987"},{"key":"10.1016\/j.autrev.2013.02.003_bb0335","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/03009749309095117","article-title":"More evidence of distinctive features of mixed connective tissue disease","volume":"22","author":"Hameenkorpi","year":"1993","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0200","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z","article-title":"Mixed connective tissue disease: to be or not to be?","volume":"41","author":"Smolen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.003_bb0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00002281-200009000-00006","article-title":"Mixed connective tissue disease","volume":"12","author":"Hoffman","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/berh.1999.0080","article-title":"Mixed connective tissue disease: overlap syndromes","volume":"14","author":"Maddison","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":"Long-term outcome in mixed connective tissue disease","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.003_bb0220","first-page":"2136","article-title":"Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease","volume":"29","author":"Bodolay","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0225","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/03009740600709790","article-title":"Regulatory T cells in peripheral blood of patients with mixed connective tissue disease","volume":"35","author":"Bar\u00e1th","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0230","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3899\/jrheum.081314","article-title":"Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels","volume":"36","author":"Hajas","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2010.11.006","article-title":"Vitamin D insufficiency in a large MCTD population","volume":"10","author":"Hajas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2013.02.003_bb0245","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","article-title":"Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED","volume":"28","author":"Moraes-Vasconcelos","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00018-011-0838-8","article-title":"Genetic disorders with immune dysregulation","volume":"69","author":"Gambineri","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2013.02.003_bb0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pcl.2012.03.010","article-title":"Immunodeficiency diseases with rheumatic manifestations","volume":"59","author":"Torgerson","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.autrev.2013.02.003_bb0260","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-3083.2011.02527.x","article-title":"Flow cytometric analysis of TCR Vbeta repertoire in patients with 22q11.2 deletion syndrome","volume":"73","author":"McLean-Tooke","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0265","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2007.02.001","article-title":"Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome","volume":"124","author":"Adriani","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0275","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0280","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2009.03.030","article-title":"TH17 cells and regulatory T cells in primary immunodeficiency diseases","volume":"123","author":"Ochs","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0285","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.1200926","article-title":"Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain","volume":"189","author":"Takezaki","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.02.003_bb0295","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.4049\/jimmunol.1100315","article-title":"Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance","volume":"186","author":"Chaturvedi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.02.003_bb0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jad.2012.03.037","article-title":"Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"141","author":"Brenu","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.autrev.2013.02.003_bb0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-10-88","article-title":"Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"10","author":"Brenu","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2013.02.003_bb0310","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2013.02.003_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0320","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.autrev.2012.02.019","article-title":"Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics","volume":"11","author":"Dong","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.003_bb0325","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.autrev.2012.02.003","article-title":"Anti-cytokine vaccination: a new biotherapy of autoimmunity?","volume":"11","author":"Semerano","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T07:25:02Z","timestamp":1562829902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1568997213000396"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.02.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies \u2014 Novel tool for diagnostics and patient follow-up","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}